Chris Welberry
PhD research at the University of Nottingham “Development and validation of an autoantibody-based blood test for hepatocellular carcinoma” provided part of the development of Oncimmune’s EarlyCDT Liver blood test for the detection of hepatocellular carcinoma. Currently a Senior Scientist at Oncimmune working on the design and development of Oncimmune’s product portfolio. Will be acting as Oncimmune’s project manager for DeLIVER.
